Drug interactions between nonsedating antihistamines and anti-infective agents

Infections in Medicine

Volumn 13, Issue 7, 1996, Pages 609-613+634

  Meyer, Joette M ^a   Rodvold, Keith A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

antifungal agents; antihistamines; astemizole; macrolides; terfenadine

Indexed keywords

ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ASTEMIZOLE; AZITHROMYCIN; CETIRIZINE; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LORATADINE; MACROLIDE; OXICONAZOLE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TERFENADINE;

DRUG INTERACTION; HEART ARRHYTHMIA; HUMAN; SHORT SURVEY;

EID: 8944261592     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. Anonymous: Top 200 drugs of 1995. Pharm Times 62:27-36, 1996.
2. Krause HF: Antihistamines and decongestants. Otolaryngol Head Neck Surg 107:835-840, 1992.
3. Monahan BP, Ferguson CL, Killeavy ES, et al: Torsades de pointes occurring in association with terfenadine use. JAMA 264:2788-2790, 1990.
4. Thompson D, Oster G: Use of terfenadine and contraindicated drugs. JAMA 275:1339-1341, 1996.
5. Zechnich AD, Hedges JR, Eiselt-Proteau D, et al: Possible interactions with terfenadine or astemizole. West J Med 160:321-325, 1994.
6. Goss JE, Ramo BW, Blake K: Torsades de pointes associated with astemizole (Hismanal) therapy. Arch Intern Med 153:2705, 1993.
7. Mathews DR, McNutt B, Okerholm R, et al: Torsades de pointes occurring in association with terfenadine use. JAMA 266:2375-2376, 1991. Letter
8. Hansten PD, Horn JR: Drug interactions with non-sedating antihistamines. Drug Interactions Newsletter: 737-741, 1994.
9. Marquardt D: Antihistamines and the heart. West J Med 158:613-614, 1993.
10. Kemp JP: Antihistamines: Is there anything safe to prescribe? Ann Allergy 69:276-280, 1992.
11. Smith SJ: Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 111:348-354, 1994.
12. Woosley RL, Chen Y, Freiman JP, et al: Mechanism of the cardiotoxic actions of terfenadine. JAMA 269:1532-1536, 1993.
13. Berul CI, Morad M: Regulation of potassium channels by nonsedating antihistamines. Circulation 91:2220-2225, 1995.
14. Rubart M, Pressler ML, Pride HP, et al: Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation 88:1832-1844, 1993.
15. Davies AJ, Harindra V, McEwan A, et al: Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 298:325, 1989. Letter.
16. Craft TM: Torades de pointes after astemizole overdose. Br Med J 292:660, 1986.
17. Snook J, Boothman-Burrell D, Watkins J, et al: Torsades de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract 42:257-259, 1988.
18. Simons FER, Kesselman MS, Giddins NG, et al: Astemizole-induced torsades de pointes. Lancet 2:624, 1988.
19. Brannan MD, Reidenberg P, Radwanski E, et al: Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther 58:269-278, 1995.
20. Sale ME, Barbey JT, Woosley RL, et al. The electrocardiographic effects of cetrizine in normal subjects. Clin Pharmacol Ther 56:295-301, 1994.
21. Gonzalez FJ: Human cytochromes P450: Problems and prospects. Trends Pharmacol Sci 13:346-352, 1992.
22. Kivisto KT, Neuvonen PJ, Klotz U: Inhibition of terfenadine metabolism: Pharmacokinetic and pharmacodynamic consequences. Clin Pharmacokinet 27:1-5, 1994.
23. Eller MG, Okerholm RA: Pharmacokinetic interaction between terfenadine and ketoconazole. Clin Pharmacol Ther 49:130, 1991. Abstract.
24. Honig PK, Wortham DC, Zamani K, et al: Terfenadine-ketoconazole interaction: Pharmacokinetic and electrocardiographic consequences. JAMA 269:1513-1518, 1993.
25. Pohjola-Sintonen S, Viitasalo M, Toivonen L, et al: Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol 45:191-193, 1993.
26. Crane JK, Shih HT: Syncope and cardiac arrhythmia due to an interaction between itraconazole and terfenadine. Am J Med 95:445-446, 1993.
27. Honig PK, Wortham DC, Hull R, et al: Itraconazole affects single-dose terfenadine pharmacokinetics and cardiac repolarization pharmacodynamics. J Clin Pharmacol 33:1201-1206, 1993.
28. Honig PK, Wortham DC, Zamani K, et al: The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans. Clin Pharmacol Ther 53:630-636, 1993.
29. Sugan AM, Sunders C, Idelson BA, et al: Interaction of fluconazole and cyclosporine. Ann Intern Med 110:844, 1989. Letter.
30. Canafax DM, Graves NM, Hilligoss DM, et al: Interaction between cyclosporine and fluconazole in renal allograft recipients. Transplantation 51:1014-1018, 1991.
31. Jurima-Romet M, Crawford K, Cyr T, et al: Terfenadine metabolism in human liver: In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab Dispos 22:849-857, 1994.
32. Cantilena LR, Sorrels S, Wiley T, et al: Fluconazole alters terfenadine pharmacokinetics and electrocardiographic pharmacodynamics. Clin Pharmacol Ther 57:185, 1995. Abstract PII-86.
33. Nattel S, Ranger S, Talajic M, et al: Erythromycin-induced long QT syndrome: Concordance with quinidine and underlying cellular electrophysiological mechanisms. Am J Med 89:235-238, 1990.
34. Biglin KE, Faraon MS, Constance TD, et al: Drug-induced torsades de pointes: A possible interaction of terfenadine and erythromycin. Ann Pharmacother 28:282, 1994.
35. Honig PK, Woosley RL, Zamani K, et al: Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52:231-238, 1992.
36. Honig PK, Wortham DC, Zamani K, et al: Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin, and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters. Drug Invest 7:148-156, 1994.
37. Harris S, Hilligoss DM, Colangelo PM, et al: Azithromycin and terfenadine: Lack of drug interaction. Clin Pharmacol Ther 58:310-315, 1995.
38. c in healthy men. Clin Pharmacol Ther 57:176, 1995. Abstract PII-51.
39. Package insert. Invirase (saquinavir mesylate). Roche Laboratories, Nutley, NJ, December 1995.
40. Package insert. Norvir (ritonavir). Abbott Laboratories, Abbott Park, Ill., February 1996.
41. Package insert. Crixivan (indinavir sulfate). Merck & Co., Inc., West Point, Pa., March 1996.
42. Cavuto NJ, Woosley RL, Sale M: Pharmacies and prevention of potentially fatal drug interactions. JAMA 275:1086-1087, 1996. Letter.
43. Griffith JS: Interaction between terfenadine and topical antifungal agents. Am Fam Physician 51:1396-1397, 1995.